prednisone has been researched along with fludarabine phosphate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Keating, MJ | 1 |
| Astrow, AB | 1 |
| Autrand, C; Binet, JL; Boudjerra, N; Cazin, B; Chastang, C; Chevret, S; Desablens, B; Dighiero, G; Divine, M; Dreyfus, B; Feugier, P; Jaubert, J; Leporrier, M; Maloum, K; Rapp, MJ; Travade, P | 1 |
| Auzerie, V; Brouet, JC; Bussel, A; Chiali, A; Dubertret, L; Fermand, JP; Senet, P | 1 |
| Buy, E; Cany, L; Eghbali, H; Guibon, O; Hoerni, B; Kind, M; Monnereau, A; Soubeyran, I; Soubeyran, P | 1 |
| de Wolf-Peeters, C; Eghbali, H; Hagenbeek, A; Hoskin, PJ; Kalmus, J; MacLennan, K; Marcus, R; Monfardini, S; Negrouk, A; Schott, A; Staab-Renner, E; Teodorovic, I; van Glabbeke, M; Vitolo, U | 1 |
2 review(s) available for prednisone and fludarabine phosphate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fludarabine phosphate in the treatment of chronic lymphocytic leukemia.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Humans; Infusions, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Prednisone; Remission Induction; Vidarabine Phosphate | 1990 |
4 trial(s) available for prednisone and fludarabine phosphate
| Article | Year |
|---|---|
Fludarabine in chronic leukaemia.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Doxorubicin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Prednisone; Vidarabine Phosphate | 1996 |
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Follow-Up Studies; Hospitalization; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Count; Male; Middle Aged; Neoplasm Staging; Phosphoramide Mustards; Prednisone; Prognosis; Proportional Hazards Models; Sample Size; Survival Rate; Time Factors; Vidarabine Phosphate; Vincristine | 2001 |
Fludarabine phosphate-CVP in patients over 60 years of age with advanced, low-grade and follicular lymphoma: a dose-finding study.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lymphoma, Follicular; Male; Maximum Tolerated Dose; Middle Aged; Prednisone; Survival Analysis; Treatment Outcome; Vidarabine Phosphate; Vincristine | 2005 |
Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Vidarabine Phosphate; Vincristine | 2006 |
1 other study(ies) available for prednisone and fludarabine phosphate
| Article | Year |
|---|---|
Leg ulcers associated with cryoglobulinemia: clinical study of 15 patients and response to treatment.
Topics: Adult; Aged; Cryoglobulinemia; Cyclophosphamide; Female; France; Humans; Infusions, Intravenous; Interferon-alpha; Leg Ulcer; Male; Medical Records; Middle Aged; Plasma Exchange; Prednisone; Retrospective Studies; Vidarabine Phosphate; Wound Healing | 2003 |